Advance your academic career, collaborate globally, and expand your network— join now !

Prof. Anna-Lise Williamson

Share Link

Share

Information

Anna-Lise Williamson is now a Professor of Virology at the University of Cape Town. She obtained her PhD from the University of the Witwatersrand in 1985. She was promoted to professor in 2004 at the University of Cape Town. Her area of expertise is human papillomavirus, but is also known on an international level for her work in developing vaccines for HIV. She was awarded a Chair in Vaccinology in 2008 (South African Research Chairs Initiative). She is a director of the UCT Vaccine Research Group GLP Facility and a Head of the WHO HPV Labnet lab for the Africa Region. She is also a member of the South African HPV Advisory Board. Now she is a virologist on the joint staff of the Division of Medical Virology, Dept of Pathology, University of Cape Town and the National Health Laboratory Service. She is internationally recognized for both HIV vaccine and Human Papillomavirus expertise. She has headed the South Africa AIDS Vaccine Initiative-funded vaccine development team since 2000.

Short Biography

Anna-Lise Williamson is now a Professor of Virology at the University of Cape Town. She obtained her PhD from the University of the Witwatersrand in 1985. She was promoted to professor in 2004 at the University of Cape Town. Her area of expertise is human papillomavirus, but is also known on an international level for her work in developing vaccines for HIV. She was awarded a Chair in Vaccinology in 2008 (South African Research Chairs Initiative). She is a director of the UCT Vaccine Research Group GLP Facility and a Head of the WHO HPV Labnet lab for the Africa Region. She is also a member of the South African HPV Advisory Board. Now she is a virologist on the joint staff of the Division of Medical Virology, Dept of Pathology, University of Cape Town and the National Health Laboratory Service. She is internationally recognized for both HIV vaccine and Human Papillomavirus expertise. She has headed the South Africa AIDS Vaccine Initiative-funded vaccine development team since 2000.